nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—ACTN2—dilated cardiomyopathy	0.0424	0.0626	CbGpPWpGaD
Pentobarbital—Ataxia—Spironolactone—dilated cardiomyopathy	0.0231	0.0717	CcSEcCtD
Pentobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—ACTN2—dilated cardiomyopathy	0.021	0.0309	CbGpPWpGaD
Pentobarbital—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.0142	0.0439	CcSEcCtD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0139	0.0205	CbGpPWpGaD
Pentobarbital—Confusional state—Spironolactone—dilated cardiomyopathy	0.0122	0.0378	CcSEcCtD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0113	0.0167	CbGpPWpGaD
Pentobarbital—Somnolence—Spironolactone—dilated cardiomyopathy	0.0107	0.0333	CcSEcCtD
Pentobarbital—GRIA2—N-cadherin signaling events—GJA1—dilated cardiomyopathy	0.0105	0.0155	CbGpPWpGaD
Pentobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0103	0.0151	CbGpPWpGaD
Pentobarbital—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00994	0.0309	CcSEcCtD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00988	0.0146	CbGpPWpGaD
Pentobarbital—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00954	0.0296	CcSEcCtD
Pentobarbital—Ataxia—Lisinopril—dilated cardiomyopathy	0.00942	0.0293	CcSEcCtD
Pentobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00934	0.0138	CbGpPWpGaD
Pentobarbital—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00889	0.0276	CcSEcCtD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00806	0.0119	CbGpPWpGaD
Pentobarbital—GRIA2—N-cadherin signaling events—RAC1—dilated cardiomyopathy	0.00799	0.0118	CbGpPWpGaD
Pentobarbital—Dizziness—Spironolactone—dilated cardiomyopathy	0.00798	0.0248	CcSEcCtD
Pentobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00785	0.0116	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00772	0.0114	CbGpPWpGaD
Pentobarbital—Vomiting—Spironolactone—dilated cardiomyopathy	0.00767	0.0238	CcSEcCtD
Pentobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00762	0.0112	CbGpPWpGaD
Pentobarbital—Rash—Spironolactone—dilated cardiomyopathy	0.00761	0.0236	CcSEcCtD
Pentobarbital—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0076	0.0236	CcSEcCtD
Pentobarbital—Headache—Spironolactone—dilated cardiomyopathy	0.00756	0.0235	CcSEcCtD
Pentobarbital—Agitation—Furosemide—dilated cardiomyopathy	0.00739	0.0229	CcSEcCtD
Pentobarbital—Nausea—Spironolactone—dilated cardiomyopathy	0.00717	0.0223	CcSEcCtD
Pentobarbital—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00706	0.0219	CcSEcCtD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00702	0.0104	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.007	0.0103	CbGpPWpGaD
Pentobarbital—Hallucination—Lisinopril—dilated cardiomyopathy	0.0069	0.0214	CcSEcCtD
Pentobarbital—GABRA6—Ion channel transport—RYR2—dilated cardiomyopathy	0.0067	0.00989	CbGpPWpGaD
Pentobarbital—Confusional state—Furosemide—dilated cardiomyopathy	0.00662	0.0206	CcSEcCtD
Pentobarbital—GABRA4—Ion channel transport—RYR2—dilated cardiomyopathy	0.00662	0.00976	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00653	0.00963	CbGpPWpGaD
Pentobarbital—GABRA6—Ion channel transport—PLN—dilated cardiomyopathy	0.00652	0.00962	CbGpPWpGaD
Pentobarbital—Shock—Furosemide—dilated cardiomyopathy	0.00646	0.0201	CcSEcCtD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00645	0.00951	CbGpPWpGaD
Pentobarbital—GABRA4—Ion channel transport—PLN—dilated cardiomyopathy	0.00644	0.0095	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00617	0.0091	CbGpPWpGaD
Pentobarbital—Hypotension—Furosemide—dilated cardiomyopathy	0.00614	0.019	CcSEcCtD
Pentobarbital—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00605	0.00893	CbGpPWpGaD
Pentobarbital—Tension—Lisinopril—dilated cardiomyopathy	0.00592	0.0184	CcSEcCtD
Pentobarbital—GRIK2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00591	0.00873	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0059	0.00871	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0059	0.0087	CbGpPWpGaD
Pentobarbital—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.00589	0.00869	CbGpPWpGaD
Pentobarbital—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.00588	0.00867	CbGpPWpGaD
Pentobarbital—Nervousness—Lisinopril—dilated cardiomyopathy	0.00586	0.0182	CcSEcCtD
Pentobarbital—Somnolence—Furosemide—dilated cardiomyopathy	0.00584	0.0181	CcSEcCtD
Pentobarbital—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00577	0.00852	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00573	0.00845	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00573	0.00845	CbGpPWpGaD
Pentobarbital—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.00572	0.00844	CbGpPWpGaD
Pentobarbital—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00567	0.00837	CbGpPWpGaD
Pentobarbital—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00564	0.00832	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00563	0.0083	CbGpPWpGaD
Pentobarbital—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00562	0.00829	CbGpPWpGaD
Pentobarbital—Constipation—Furosemide—dilated cardiomyopathy	0.00561	0.0174	CcSEcCtD
Pentobarbital—CHRNA7—Neuronal System—ABCC9—dilated cardiomyopathy	0.00561	0.00828	CbGpPWpGaD
Pentobarbital—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00554	0.00817	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00553	0.00816	CbGpPWpGaD
Pentobarbital—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.00552	0.00814	CbGpPWpGaD
Pentobarbital—Angioedema—Lisinopril—dilated cardiomyopathy	0.00552	0.0171	CcSEcCtD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00549	0.0081	CbGpPWpGaD
Pentobarbital—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.00548	0.00809	CbGpPWpGaD
Pentobarbital—Syncope—Lisinopril—dilated cardiomyopathy	0.00541	0.0168	CcSEcCtD
Pentobarbital—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00541	0.0168	CcSEcCtD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00539	0.00796	CbGpPWpGaD
Pentobarbital—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.00539	0.00794	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—ACTN2—dilated cardiomyopathy	0.00538	0.00794	CbGpPWpGaD
Pentobarbital—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00531	0.0165	CcSEcCtD
Pentobarbital—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00519	0.0161	CcSEcCtD
Pentobarbital—Anxiety—Lisinopril—dilated cardiomyopathy	0.00512	0.0159	CcSEcCtD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00499	0.00736	CbGpPWpGaD
Pentobarbital—Confusional state—Lisinopril—dilated cardiomyopathy	0.00497	0.0154	CcSEcCtD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00491	0.00724	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00485	0.00715	CbGpPWpGaD
Pentobarbital—Shock—Lisinopril—dilated cardiomyopathy	0.00485	0.015	CcSEcCtD
Pentobarbital—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00484	0.00714	CbGpPWpGaD
Pentobarbital—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00484	0.015	CcSEcCtD
Pentobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—dilated cardiomyopathy	0.00477	0.00704	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00472	0.00696	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00471	0.00696	CbGpPWpGaD
Pentobarbital—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00471	0.00694	CbGpPWpGaD
Pentobarbital—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00466	0.00687	CbGpPWpGaD
Pentobarbital—Hypotension—Lisinopril—dilated cardiomyopathy	0.0046	0.0143	CcSEcCtD
Pentobarbital—CHRNA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00458	0.00675	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00452	0.00667	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00443	0.00654	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00439	0.00647	CbGpPWpGaD
Pentobarbital—Somnolence—Lisinopril—dilated cardiomyopathy	0.00438	0.0136	CcSEcCtD
Pentobarbital—Dizziness—Furosemide—dilated cardiomyopathy	0.00434	0.0135	CcSEcCtD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00431	0.00635	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00423	0.00624	CbGpPWpGaD
Pentobarbital—Constipation—Lisinopril—dilated cardiomyopathy	0.00421	0.0131	CcSEcCtD
Pentobarbital—Vomiting—Furosemide—dilated cardiomyopathy	0.00417	0.013	CcSEcCtD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00416	0.00613	CbGpPWpGaD
Pentobarbital—Rash—Furosemide—dilated cardiomyopathy	0.00414	0.0129	CcSEcCtD
Pentobarbital—Dermatitis—Furosemide—dilated cardiomyopathy	0.00414	0.0128	CcSEcCtD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00413	0.00609	CbGpPWpGaD
Pentobarbital—Headache—Furosemide—dilated cardiomyopathy	0.00411	0.0128	CcSEcCtD
Pentobarbital—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00406	0.0126	CcSEcCtD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00406	0.00598	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00392	0.00579	CbGpPWpGaD
Pentobarbital—Nausea—Furosemide—dilated cardiomyopathy	0.0039	0.0121	CcSEcCtD
Pentobarbital—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00389	0.0121	CcSEcCtD
Pentobarbital—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00387	0.00572	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00386	0.00569	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00376	0.00555	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00371	0.00548	CbGpPWpGaD
Pentobarbital—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00363	0.0113	CcSEcCtD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00354	0.00523	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00354	0.00523	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00344	0.00508	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.0034	0.00501	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00338	0.00499	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00334	0.00493	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00332	0.0049	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.0033	0.00487	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.0033	0.00487	CbGpPWpGaD
Pentobarbital—Dizziness—Lisinopril—dilated cardiomyopathy	0.00326	0.0101	CcSEcCtD
Pentobarbital—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00324	0.00478	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00324	0.00478	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00318	0.0047	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00316	0.00467	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00314	0.00464	CbGpPWpGaD
Pentobarbital—Vomiting—Lisinopril—dilated cardiomyopathy	0.00313	0.00972	CcSEcCtD
Pentobarbital—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00311	0.00458	CbGpPWpGaD
Pentobarbital—Rash—Lisinopril—dilated cardiomyopathy	0.00311	0.00964	CcSEcCtD
Pentobarbital—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0031	0.00963	CcSEcCtD
Pentobarbital—Headache—Lisinopril—dilated cardiomyopathy	0.00309	0.00958	CcSEcCtD
Pentobarbital—Nausea—Lisinopril—dilated cardiomyopathy	0.00293	0.00908	CcSEcCtD
Pentobarbital—GRIA2—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00292	0.0043	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00283	0.00418	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00273	0.00402	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00272	0.00401	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00263	0.00389	CbGpPWpGaD
Pentobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00234	0.00345	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00233	0.00344	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0023	0.0034	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00227	0.00335	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00227	0.00335	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00224	0.00331	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00224	0.00331	CbGpPWpGaD
Pentobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00213	0.00314	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00211	0.00311	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00211	0.00311	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00208	0.00307	CbGpPWpGaD
Pentobarbital—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00206	0.00305	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00205	0.00302	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00205	0.00302	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00205	0.00302	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00204	0.00301	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00201	0.00296	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00199	0.00294	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00199	0.00294	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00197	0.00291	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00196	0.00289	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00195	0.00288	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00195	0.00288	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00195	0.00287	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00193	0.00284	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00192	0.00283	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00192	0.00283	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00191	0.00282	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00191	0.00282	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00191	0.00281	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00187	0.00276	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00187	0.00276	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00185	0.00273	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00184	0.00272	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00182	0.00268	CbGpPWpGaD
Pentobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00179	0.00264	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00179	0.00263	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00177	0.00262	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00176	0.00259	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00175	0.00258	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00174	0.00257	CbGpPWpGaD
Pentobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00173	0.00256	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00169	0.00249	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00168	0.00248	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00164	0.00242	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00164	0.00242	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.0016	0.00236	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00152	0.00225	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00149	0.00219	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00147	0.00216	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—RAF1—dilated cardiomyopathy	0.00135	0.00199	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00134	0.00198	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00134	0.00198	CbGpPWpGaD
Pentobarbital—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.00132	0.00195	CbGpPWpGaD
Pentobarbital—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.00131	0.00193	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.0013	0.00192	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.0013	0.00192	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00128	0.00189	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00128	0.00188	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00127	0.00188	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00126	0.00186	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00125	0.00184	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00123	0.00181	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—RAF1—dilated cardiomyopathy	0.00122	0.00181	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00122	0.0018	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0012	0.00177	CbGpPWpGaD
Pentobarbital—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00119	0.00176	CbGpPWpGaD
Pentobarbital—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.00116	0.00171	CbGpPWpGaD
Pentobarbital—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.00114	0.00168	CbGpPWpGaD
Pentobarbital—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00112	0.00165	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00112	0.00165	CbGpPWpGaD
Pentobarbital—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.00111	0.00164	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.0011	0.00163	CbGpPWpGaD
Pentobarbital—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00109	0.00161	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00107	0.00158	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00104	0.00153	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—RAF1—dilated cardiomyopathy	0.00103	0.00152	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00101	0.00149	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000998	0.00147	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00098	0.00145	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000962	0.00142	CbGpPWpGaD
Pentobarbital—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000955	0.00141	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000946	0.0014	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00094	0.00139	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000933	0.00138	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000923	0.00136	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	0.000877	0.00129	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000856	0.00126	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000845	0.00125	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000806	0.00119	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	0.000793	0.00117	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000773	0.00114	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000751	0.00111	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000737	0.00109	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000725	0.00107	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.00072	0.00106	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000707	0.00104	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000642	0.000948	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000618	0.000912	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000569	0.000839	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000535	0.000789	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000484	0.000714	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00046	0.000679	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000454	0.00067	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000416	0.000613	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000404	0.000596	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000396	0.000585	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00039	0.000575	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000387	0.000571	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00038	0.000561	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000342	0.000505	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000332	0.00049	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000322	0.000474	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000295	0.000435	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000291	0.000429	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000287	0.000424	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000259	0.000382	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	0.000216	0.000318	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	0.00021	0.00031	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	0.000189	0.000279	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	0.000131	0.000194	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	0.000128	0.000189	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	0.000115	0.00017	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	7.9e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	7.7e-05	0.000114	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	6.93e-05	0.000102	CbGpPWpGaD
